Latest Welcure Drugs & Pharmaceuticals stock price
Welcure Drugs & Pharmaceuticals P/E Ratio
WELCURE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
1.5
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
1.5
Current Price
₹0.42
EPS (TTM)
₹0.36
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
53.8
Sector Median
31.12
Sector Rank
#1 of 131
Sector Percentile
0.8%
Key P/E Ratio Insights for Welcure Drugs & Pharmaceuticals
- Stock appears undervalued with PE of 1.5, suggesting potential buying opportunity
- Trading at discount to sector average PE of 53.8
View the WELCURE equity price for detailed stock performance.
Related Pages for Welcure Drugs & Pharmaceuticals
Additional stock information and data for WELCURE
Sector P/E Ratio Comparison
Comparing Welcure Drugs & Pharmaceuticals with other companies in Healthcare sector
Sector Average
53.8
Sector Median
31.12
Lowest P/E
3.18
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |